Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples